We discuss the use of sildenafil in a patient who sustained a massive pulmonary embolism (PE). She remained haemodynamically unstable after thrombolysis, and needed large doses of inotropic support. She was treated with oral sildenafil at a dose of 75 mg three times a day which enabled weaning from inotropic support and clinical improvement.
British Thoracic Society Standards of Care Committee Pulmonary Embolism Guideline Development Group. British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax2003;58: 470–84.
2.
StratmannGGregoryGA. Neurogenic and humoral vasoconstriction in acute pulmonary embolism. Anesth Analg2003;97: 341–54.
3.
SmuldersYM. Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: the pivotal role of pulmonary vasoconstriction. Cardiovasc Res2000;40: 23–33.
4.
CroomKFCurranMP. Sildenafil – A review of its use in pulmonary arterial hypertension. Drugs2008;68: 383–97.
5.
Souza-SilvaARDias-JuniorCAUzuelliJAHemodynamic effects of combined sildenafil and L-arginine during acute pulmonary embolism-induced pulmonary hypertension. Eur J Pharm2005;524: 126–31.
6.
Dias-JuniorCATanus-SantosJE. Haemodynamic effects of sildenafil interaction with a nitric oxide donor compound in a dog model of acute pulmonary embolism. Life Sci2006;79: 469–74.
7.
Dias-JuniorCA. The use of sildenafil in the therapy of massive pulmonary embolism. Intensive Care Med2006;32: 1284.
8.
GanièreVFeihlFTaganD. Dramatic beneficial effects of sildenafil in recurrent massive PE. Intensive Care Med2006;32: 452–54.
Dias-JuniorCASouza-CostaDCZerbiniTThe effect of sildenafil on pulmonary embolism-induced oxidative stress and pulmonary hypertension. Anesth Anal2005;101: 115–20.
